Ondine Biomedical Inc (OBI) - Total Liabilities

Latest as of December 2025: GBX10.91 Million GBX ≈ $1.33K USD

Based on the latest financial reports, Ondine Biomedical Inc (OBI) has total liabilities worth GBX10.91 Million GBX (≈ $1.33K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ondine Biomedical Inc - Total Liabilities Trend (2001–2025)

This chart illustrates how Ondine Biomedical Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Ondine Biomedical Inc to evaluate short-term liquidity relative to the company's equity base.

Ondine Biomedical Inc Competitors by Total Liabilities

The table below lists competitors of Ondine Biomedical Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Alveen PA:MLALV	France	€792.00K
EJF Investments Ltd LSE:EJFI	UK	GBX20.85 Million
Tarku Resources Ltd V:TKU	Canada	CA$1.12 Million
Aker Horizons AS OL:AKH	Norway	Nkr21.20 Billion
Braemar Plc LSE:BMS	UK	GBX69.89 Million
Geneuro SA PA:GNRO	France	€20.14 Million

Liability Composition Analysis (2001–2025)

This chart breaks down Ondine Biomedical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ondine Biomedical Inc stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.76	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ondine Biomedical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ondine Biomedical Inc (2001–2025)

The table below shows the annual total liabilities of Ondine Biomedical Inc from 2001 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX10.91 Million ≈ $1.33K	+83.50%
2024-12-31	GBX5.95 Million ≈ $723.33	+62.92%
2023-12-31	GBX3.65 Million ≈ $443.98	-25.91%
2022-12-31	GBX4.92 Million ≈ $599.23	+9.86%
2021-12-31	GBX4.48 Million ≈ $545.45	-87.71%
2020-12-31	GBX36.46 Million ≈ $4.44K	+25.80%
2019-12-31	GBX28.99 Million ≈ $3.53K	+29.42%
2018-12-31	GBX22.40 Million ≈ $2.72K	+84.24%
2017-12-31	GBX12.16 Million ≈ $1.48K	+439.10%
2010-12-31	GBX2.25 Million ≈ $274.35	+68.11%
2009-12-31	GBX1.34 Million ≈ $163.19	-16.65%
2008-12-31	GBX1.61 Million ≈ $195.79	-25.50%
2007-12-31	GBX2.16 Million ≈ $262.81	+15.34%
2006-12-31	GBX1.87 Million ≈ $227.85	+151.16%
2005-12-31	GBX745.61K ≈ $90.72	+218.65%
2003-08-31	GBX233.99K ≈ $28.47	+62.35%
2002-08-31	GBX144.13K ≈ $17.54	+148.43%
2001-08-31	GBX58.02K ≈ $7.06	--

About Ondine Biomedical Inc

LSE:OBI UK Biotechnology

Market Cap

$916.61K

GBX7.53 Billion GBX

Market Cap Rank

#30562 Global

#823 in UK

Share Price

GBX14.50

Change (1 day)

+0.00%

52-Week Range

GBX8.00 - GBX18.00

All Time High

GBX58.50